Effectiveness of medium-dose ultraviolet A1 phototherapy in localized scleroderma

International Journal of Dermatology

Volumn 50, Issue 8, 2011, Pages 1006-1013

  Su, Ozlem ^a   Onsun, Nahide ^a   Onay, Hulya Kapran ^b   Erdemoglu, Yeliz ^a   Ozkaya, Dilek Biyik ^a   Cebeci, Filiz ^a   Somay, Adnan ^b  

^a BEZMIALEM VAKIF UNIVERSITY   (Turkey)

^b Vakif Gureba Teaching and Research Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; FEMALE; HISTOPATHOLOGY; HUMAN; LOCALIZED SCLERODERMA; MALE; PHOTOTHERAPY; PRESCHOOL CHILD; SCHOOL CHILD; SCORING SYSTEM; SKIN BIOPSY; SKINFOLD THICKNESS; THERAPY EFFECT; ULTRAVIOLET A1 PHOTOTHERAPY;

ADOLESCENT; ADULT; AGED; BIOPSY; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; MALE; MIDDLE AGED; SCLERODERMA, LOCALIZED; SKIN; TREATMENT OUTCOME; ULTRAVIOLET THERAPY; YOUNG ADULT;

EID: 79960618957     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2010.04843.x     Document Type: Article

References (33)

1. Laxer RM, Zulian F. Localized scleroderma. Curr Opin Rheumatol 2006; 18: 606-613.
2. Zulian F. New developments in localized scleroderma. Curr Opin Rheumatol 2008; 20: 601-607.
3. Rosenwasser TA, Eisen AZ. Scleroderma. Fitzpatrick TB, Eisen AZ, Wolff K, et al., eds. Dermatology in General Medicine, 4th edn. New York: McGraw-Hill Book Company, 1993: 2156-2167.
4. de Rie MA, Enomoto DHN, de Vries HJC, Bos JD. Evaluation of medium-dose UVA1 phototherapy in localized scleroderma with the cutometer and fast Fourier transform method. Dermatology 2003; 207: 298-301.
5. Lever WF, Schaumburg-Lever G. Histopathology of the Skin, 8th edn. Philadelphia: JB. Lippincott, 1997: 274-285.
6. Uitto J, Santa Cruz DJ, Baver EA, Eisen AZ. Morphea and lichen sclerosis et atrophicus. Clinical and histopathological studies in patients with combined features. J Am Acad Dermatol 1980; 3: 271-279.
7. Rowell NR, Goodfield MJD. The connective diseases. Champion RH, Burton JL, Ebling FJG, eds. Textbook of Dermatology. Oxford: Blackwell Scientific Publications; 1992: 2163-2194.
8. Sator PG, Radakovic S, Schulmeister K, et al. Medium-dose is more effective than low dose ultraviolet A1 phototherapy for localized scleroderma as shown by 20MHz ultrasound assessment. J Am Acad Dermatol 2009; 60: 786-791.
9. Hatomochi A, Ono M, Arakawa M, et al. Analysis of collagen gene expression by cultured fibroblasts in morphea. Br J Dermatol 1992; 126: 216-221.
10. Scharffetter Kochanek K, Goldermann R, Lehmann P, et al. PUVA therapy in disabling pansclerotic morphea of children. Br J Dermatol 1995; 132: 830-831.
11. El-Mofty M, Zaher H, Basseila M. Low dose broad-band UVA in morphea using a new method for evaluation. Photodermatol Photoimmunol Photomed 2000; 16: 43-49.
12. Kreuter A, Hyun J, Stücker M, et al. A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma. J Am Acad Dermatol 2006; 54: 440-447.
13. Stege H, Berneburg M, Humke S, et al. High-dose UVA1 radiation therapy for localized scleroderma. J Am Acad Dermatol 1997; 36: 938-944.
14. Kerscher M, Volkanandt M, Gruss C, et al. Low-dose UVA1 phototherapy for treatment of localized scleroderma. J Am Acad Dermatol 1998; 38: 21-26.
15. Kroft EBM, Berkhof NJG, van de Kerkhof PCM, et al. Ultraviolet A phototherapy for sclerotic skin disease: a systematic review. J Am Acad Dermatol 2008; 59: 1017-1030.
16. Steger JW, Matthews JH. UVA therapy for scleroderma. J Am Acad Dermatol 1999; 40: 787-788.
17. Rook AH, Freundlich B, Jegasothy BV, et al. Treatment of systemic sclerosis with extracorporeal photo chemotherapy. Arch Dermatol 1992; 28: 337-346.
18. Gross CJ, von Kobyletzki G, Behrens-Williams SC, et al. Effects of low dose ultraviolet A-1 phototherapy on morphea. Photodermatol Photoimmunol Photomed 2001; 17: 148-155.
19. Camacho NR, Sanchez JE, Martin RF, et al. Medium-dose UVA1 phototherapy in localized scleroderma and its effect in CD34-positive dendritic cells. J Am Acad Dermatol 2001; 45: 697-699.
20. Tuchinda C, Kerr HA, Taylor CR, et al. UVA1 phototherapy for cutaneous diseases: an experience of 92 cases in the United States. Photodermatol Photoimmunol Photomed 2006; 22: 247-253.
21. Grewe M, Gyufko K, Krutmann J. Interleukin-10 production by cultured human keratinocytes: regulation by ultraviolet B and ultraviolet A1 radiation. J Invest Dermatol 1995; 104: 3-6.
22. Baadsgacid O, Lisby S, Lange Kantzin G, et al. Rapid recovery of Langerhans cell alloreactivity, without induction of autoreactivity, after in vivo ultraviolet A1, but not ultraviolet B exposure of human cells. J Immunol 1989; 142: 4213-4218.
23. Krutmann J. Ultraviolet A1 radiation-induced immunomodulation: high-dose UVA1 therapy of atopic dermatitis. Krutmann J, Elmets CA, eds. Photoimmunology. Oxford: Blackwell Science Ltd. 1995: 246-256.
24. Gruss C, Reed JA, Altmeyer P, et al. Induction of interstitial collagenase (MMP-1) by UVA1 phototherapy in morphea fibroblasts. Lancet 1997; 350: 1295-1296.
25. Grabbe J, Welker P, Humke S, et al. High-dose UVA1, but not UVA/UVB therapy decreases IgE binding cells in lesional skin of patients with atopic eczema. J Invest Dermatol 1996; 107: 419-422.
26. Scharffetter K, Wlaschek M, Hogg A, et al. UVA irradiation induces collagenase in human dermal fibroblasts in vitro and in vivo. Arch Dermatol Res 1991; 283: 506-511.
27. Wlaschek M, Heinen G, Postwig A, et al. UVA-induced autocrine stimulation of fibroblast-derived-collagenase/MMP.1 by interrelated loops of interleukin-1 and interleukin-6. Photochem Photobiol 1994; 59: 550-556.
28. Breuchkmann F, Stuocker M, Altmeyer P, Kreuter A. Modulation of endothelial dysfunction and apoptosis: UVA1-mediated skin improvement in systemic sclerosis. Arch Dermatol Res 2004; 296: 235-239.
29. Petersen MJ, Wason C, Craig S. Ultraviolet A irradiation stimulates collagenase production in cultured human fibroblast. J Invest Dermatol 1992; 99: 440-444.
30. Hoffmann K, Gerbaulet U, El-Gammal S, Altmeyer P. 20 MHz B-mode ultrasound in monitoring the course of localized scleroderma (morphea). Acta Derm Venereol Suppl (Stockh) 1991; 164(Suppl.): 3-16.
31. Kreuter A, von Kobyletzki G, Happe M, et al. Ultraviolet-A1 (UVA1) phototherapy in lichen sclerosis et atrophicus. Hautarzt 2001; 52: 878-881.
32. Tosnes A, Anglade MC, Revaz J, Radier C. Thirteen-megahertz ultrasound probe: its role in diagnosing localized scleroderma. Br J Dermatol 2003; 148: 724-729.
33. Dawe RS. Ultraviolet A1 phototherapy. Br J Dermatol 2003; 148: 626-637.